## 治療用途
- 抗心律不整
	- Class II
## MOA
- $\beta_{1}$-blocker
- blockade of Na<sup>+</sup> channels
## 藥動
- 峰值濃度出現在攝入後1至3小時內
- 有 [[First-pass effect]] 
	- 口服加大藥量
- 代謝依賴於肝血流
	- 本身會降低肝血流
- 口服/靜脈注射比值高 - 40:1
- ==如與食物一同服用
	- bioavailability 高
## 副作用
- 氣喘
## Blood Pressure
- No direct and acute action on Blood Pressure
- But beneficial in hypertensives on prolonged administration
- Normally, propranolol would block CA induced vasodilatation and cause increase in TPR and decrease in cardiac output – but negligible change in BP 
- Decreased Renin release (β<sub>1</sub>)
- Central reduction of sympathetic outflow
## Actions
- **Respiratory**
	- ==Bronchoconstriction== due to blockade of $\beta_{2}$ receptors
	- Not considerable in normal individual 
		- May be dangerous in presence of asthma (avoid)
- **Eye**: 
	- Decreases IOP by reducing production of aqueous humor 房水
	- glaucoma
- **CNS**: 
	- No considerable CNS effect except 
		- behavioural, forgetfulness and nightmare etc.
	- Suppresses anxiety
- **Skeletal Muscle**: 
	- Reduction of Tremor
	- Reduction of exercise capacity: 
		- reduction in blood flow, glycogenolysis and lipolysis
- **Metabolic**
	- Lipid: 
		- Inhibits sympathetic stimulation of lipolysis and consequent increase in free fatty acid level 
		- triglyceride level increased. LDL/HDL ratio increases
	- Carbohydrate: 
		- Inhibition of glycogenolysis in heart, muscle and liver 
			- β<sub>2</sub> mediated
	- Recovery from insulin action delayed
	- Warning signs are masked
	- β<sub>1</sub> selective are much safer in patients with diabetes
## ADRs
- Bradycardia
- Respiratory: 
	- Bronchial asthma (life threatening asthma)
- Risk of Coronary Heart Disease (triglyceride and LDL increase and fall in HDL)
- Tiredness and reduced exercise capacity 
	- $\beta_{2}$ muscle
- Variant angina exacerbation 
	- unopposed coronary constriction by $\alpha$ receptor
- Cold hands and feet 
	- worsening of Peripheral vascular disease
- Withdrawal
- Others: 
	- GIT upset, nightmare, forgetfulness and sexual distress
## Eutomer and Distomer
+ **Eutomer**:
	(S) active form​Of two enantiomeric compounds, the one with the stronger chemical activity. It causes beneficial effects when it is administered
+ **Distomer**:
	(R) 
	The enantiomer or stereoisomer with the lesser activity at or affinity for a given receptor, one receptors distomer can be another receptor’s eutomer